| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |